4
Changes in Ownership
Niagen Bioscience, Inc. Filed Acc 0001628280-25-008721
Options or other derivatives
- Chief Executive Officer acquired 1,518,600 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Fried Robert N · Chief Executive Officer
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-02-25 | Grant or award : show line 1 in the form Performance Stock Unit | +1,518,600 | 1,518,600 | D |
Loading xslF345X05/wk-form4_1740692548.xml…